Kangmei Pharmaceutical Co., Ltd. (SHA:600518)

China flag China · Delayed Price · Currency is CNY
1.790
-0.050 (-2.72%)
At close: Mar 20, 2026
Market Cap24.75B -20.3%
Revenue (ttm)5.28B +1.2%
Net Income16.64M -93.5%
EPS0.00 -93.5%
Shares Out13.83B
PE Ratio1,487.56
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume231,698,408
Average Volume169,890,882
Open1.830
Previous Close1.840
Day's Range1.790 - 1.850
52-Week Range1.790 - 2.280
Beta0.77
RSI29.29
Earnings DateApr 18, 2026

About Kangmei Pharmaceutical

Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China. The company offers Chinese patent medicines, chemical medicines, and health food products. In addition, it engages in the operation of Chinese medicinal materials markets; production and sale of medical devices; and operation of pharmaceutical logistics system. The company provides its products through medical institution resources, smart pharmacies, OTC retail, chain drug stores, direct sales, medical e-commerce, mobile medical care, etc. Kangmei Pharmaceuti... [Read more]

Sector Healthcare
Founded 1997
Employees 4,233
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600518
Full Company Profile

Financial Performance

In 2024, Kangmei Pharmaceutical's revenue was 5.19 billion, an increase of 6.47% compared to the previous year's 4.87 billion. Earnings were 8.57 million, a decrease of -91.64%.

Financial Statements